IRIS CF assists Ceban in the acquisition of Bipharma

Ceban has acquired the shares of Bipharma. IRIS CF advised Ceban in this transaction.


The Centrale Bereidings Apotheek Nederland (Ceban) is a modern GMP central compounding pharmacy in Breda that supplies nationwide. Ceban specialises in the preparation of medications based on individual patient prescriptions. Together with Medsen Apotheek, Ceban is a porfolio company of Bencis Capital Partners. IRIS CF advised the buyer during the transaction process. 

For more information see:


Bipharma is a company involved in the sales, marketing, distribution and logistics services related to pharmaceutical products and in-vitro diagnostic solutions in the Benelux.

For more information see:

Strategic combination

The acquisition of Bipharma makes the Ceban Group the complete partner in the field of pharmacy preparations and neutral creams and ointments.